M.D. Anderson Holds First Cancer Meeting in Spanish

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 7
Volume 4
Issue 7

HOUSTON--Spanish-speaking oncologists from around the world stopped off in Houston on their way home from the ASCO meeting to learn more about state-of-the-art cancer care--in their own language.

HOUSTON--Spanish-speaking oncologists from around the world stoppedoff in Houston on their way home from the ASCO meeting to learnmore about state-of-the-art cancer care--in their own language.

The University of Texas M.D. Anderson Cancer Center sponsoredthe 2-day Conferencia Internacional de Oncologist Medica, thefirst ever to be presented exclusively in Spanish at the cancercenter.

"M.D. Anderson is probably the only center in the countrythat could put together such a program in Spanish. At least onephysician or researcher in each of our major services speaks fluentSpanish, and these faculty are on the conference program,"said Dr. Richard Pazdur, assistant vice president of academicaffairs and a conference organizer.

About 5% of M.D. Anderson's patients come from other countriesand most of them speak Spanish. To assist these patients, theCenter has established the International Patient Center, a patientfamily hotel where multilingual staff serve as advocates for patientsfar from home.

Recent Videos
Educating community practices on CAR T referral and sequencing treatment strategies may help increase CAR T utilization.
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
9 Experts are featured in this series.
9 Experts are featured in this series.
Harmonizing protocols across the health care system may bolster the feasibility of giving bispecifics to those with lymphoma in a community setting.
2 experts are featured in this series.
Patients who face smoking stigma, perceive a lack of insurance, or have other low-dose CT related concerns may benefit from blood testing for lung cancer.
9 Experts are featured in this series.
Related Content